Status:
COMPLETED
Mortality Due to COVID-19 in the COVID-AGEBRU Study
Lead Sponsor:
Brugmann University Hospital
Conditions:
Covid19
Old Age; Debility
Eligibility:
All Genders
70+ years
Brief Summary
The COVID-Age Brugmann study aims to identify the clinical predictors of mortality risk in older patients admitted to an acute care unit due to COVID-19
Detailed Description
The COVID-19 disease has been shown to be associated to higher mortality risk and health adverse consequences. Despite of the fact that the SAR-COV2 virus has been shown that affects every populations...
Eligibility Criteria
Inclusion
- Patients aged 70 and older
- Patients admitted to an acute care geriatric unit due to COVID-19
- Patients with COVID-19 by PCR, serology or CT scan suggestive of this disease
Exclusion
- No other demographic or clinical exclusion criteria will be applied
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04756479
Start Date
March 1 2020
End Date
June 30 2020
Last Update
April 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Brugmann
Brussels, Belgium, 1020